Sunday, February 17, 2019
Tags Immunotherapy Cocktails

Tag: Immunotherapy Cocktails

Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

Study Preserves Hopes for Roche’s Tecentriq in Lung Cancer

By John Miller ZURICH (Reuters)  Swiss drugmaker Roche's hopes of having the first immunotherapy cocktail to be approved as an initial treatment for an aggressive form...
Bottles of medications line the shelves at a pharmacy in Portsmouth

Roche Drugs Show Limited Benefit in Lung, Breast Cancer Trials

By Deena Beasley CHICAGO (Reuters)  In a disappointment for Roche Holding AG, two of its oncology drugs provided only modest protection from disease progression in lung...
Swiss drugmaker Roche's logo is seen at their headquarters in Basel, Switzerland

Roche, Chasing Merck, Notches Another Lung Cancer Win

By John Miller ZURICH (Reuters) Roche's bid to keep Merck's cancer blockbuster Keytruda within striking distance got a lift on Tuesday when the Swiss drugmaker...
A man walks past a sign at an AstraZeneca site in Macclesfield

AstraZeneca Flop a Fresh Blow to Cancer Immunotherapy Combination

By Ben Hirschler LONDON (Reuters) The concept of combining two immunotherapy drugs to fight lung cancer - not so long ago one of the hottest ideas...
The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, Switzerland.

Roche’s Tecentriq Cocktail Adds to Lung Cancer Survival Success

ZURICH (Reuters) Roche's Tecentriq immunotherapy combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss company said as it seeks...
Swiss drugmaker Roche's logo is seen at their headquarters in Basel

Roche’s Tecentriq Notches Third Cancer Cocktail Trial Win

By John Miller ZURICH (Reuters) Roche's immunotherapy Tecentriq on Tuesday racked up a third trial win in combination with other cancer drugs, a boost for...